Administration of dexamethasone protects mice against ischemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling.

Authors:
  • YYYing Yao
    Ying Yao
  • FXFang Xiao
    Fang Xiao
  • XLXiaoqin Lan
    Xiaoqin Lan
  • CYChong Yu
    Chong Yu
  • YZYing Zhang
    Ying Zhang
  • CJCao Jiang
    Cao Jiang
  • JYJuan Yang
    Juan Yang
  • GPGuangchang Pei
    Guangchang Pei
  • YLYueqiang Li
    Yueqiang Li
  • SRSong Rong
    Song Rong
  • SHShuang Hu
    Shuang Hu
Google Scholar
Abstract
Dexamethasone (DEX), a ligand for glucocorticoid receptor (GR), has long been used in the clinical practice due to its anti-inflammatory and immunosuppressive properties. Given that ischemia/reperfusion (IR)-induced renal injury is featured by the excessive immune response; the current study is therefore designed to address the impact of dexamethasone on IR-induced renal injury, a common disorder in the clinical settings. Precondition of mice with 4 mg/kg of dexamethasone significantly attenuated IR-induced injury as manifested by the improved renal function along with ameliorated pathological changes and suppressed inflammatory infiltration. Mechanistic studies revealed that dexamethasone promotes GR activation, and by which it attenuates the signals for PI3K/AKT activation. Attenuated PI3K/AKT signaling thus suppresses inflammatory response which then protects kidneys from IR-induced injury. All together, our data support that dexamethasone could be a good alternative therapy for prevention and treatment of IR-induced renal injury in the clinical practice.

This publication has 29 references indexed in Scilit: